Trials / Conditions / BRIP1 Gene Mutation

BRIP1 Gene Mutation

8 registered clinical trials studyying BRIP1 Gene Mutation — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Withdrawn	Niraparib, Abiraterone Acetate and Prednisone for mHSPC With Deleterious Homologous Recombination Repair Alter NCT06392841	Qian Qin	Phase 2
Recruiting	An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk a NCT05420064	Memorial Sloan Kettering Cancer Center	N/A
Recruiting	TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention NCT04294927	University Medical Center Nijmegen	N/A
Active Not Recruiting	Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response NCT04030559	Marc Dall'Era, MD	Phase 2
Active Not Recruiting	Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome NCT04009148	NYU Langone Health	—
Active Not Recruiting	Olaparib In Metastatic Breast Cancer NCT03344965	Beth Israel Deaconess Medical Center	Phase 2
Suspended	Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible) NCT02993068	M.D. Anderson Cancer Center	N/A
Completed	Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer NCT03377556	SWOG Cancer Research Network	Phase 2